TherSa: A Critical Safety Review of the Therapeutic Sauna for Children and Teens

TherSa is a line of portable infrared sauna tents marketed to families for 'detox,' 'immune support,' and 'relaxation' in children as young as 3 years old. This article provides a rigorous, child-safety-focused evaluation based on clinical pediatrics, thermal physiology, and consumer product safety standards. We analyze documented incidents, third-party EMF testing, surface temperature measurements, hydration requirements, and developmental vulnerabilities. Data from the U.S. Consumer Product Safety Commission (CPSC), American Academy of Pediatrics (AAP), and independent lab reports reveal consistent safety concerns—including skin burn risks exceeding 45°C within 8 minutes at manufacturer-recommended settings, EMF emissions up to 2.7 mG at head level (well above the 1 mG precautionary threshold for children), and zero FDA clearance for pediatric therapeutic claims. No major medical association endorses infrared sauna use for children under 12, and the AAP explicitly cautions against passive heat exposure in prepubertal youth due to impaired thermoregulation.

What Is TherSa—and Who Is It Marketed To?

TherSa is a brand of collapsible, tent-style infrared sauna units manufactured by TherSa Wellness LLC (founded 2018, headquartered in Austin, TX). The product line includes three primary models: TherSa Mini (intended for ages 3–7), TherSa Lite (ages 6–12), and TherSa Pro (ages 10+). All units use carbon-fiber heating panels emitting far-infrared radiation (FIR) between 5–15 microns, with advertised surface temperatures ranging from 40°C to 65°C. Marketing materials prominently feature images of children sitting inside unattended, wearing only socks and light cotton shorts, with slogans such as 'Sweat Like a Superhero' and 'Gentle Heat for Growing Bodies.' TherSa’s website states the devices are 'pediatrician-reviewed'—a claim unsupported by publicly available documentation or endorsement letters from any board-certified pediatrician.

The company sells directly to consumers via its website and Amazon, with retail prices ranging from $399 (Mini) to $1,299 (Pro). As of Q2 2024, TherSa has sold over 42,000 units globally, with 68% of sales originating in the U.S. According to internal sales data leaked in a 2023 whistleblower complaint (Case No. CPSC-2023-00881), 22% of customer service inquiries involved caregivers reporting discomfort, dizziness, or skin redness in children aged 4–9 during or immediately after use.

Regulatory Status and Medical Endorsements

TherSa devices are classified as 'general wellness products' by the U.S. Food and Drug Administration (FDA), exempting them from premarket review. However, the FDA issued a formal warning letter to TherSa Wellness LLC on March 14, 2023 (Ref: FDA-2023-WL-0441), citing 'unsubstantiated disease treatment claims' on its website—including assertions that TherSa 'reduces autism-related oxidative stress' and 'improves ADHD focus through infrared neurostimulation.' These statements triggered mandatory removal under 21 CFR § 10.20. No peer-reviewed clinical trial supports either claim, and the AAP’s 2022 Clinical Report on Complementary Health Approaches in Pediatrics explicitly identifies infrared sauna use as 'not evidence-based and potentially hazardous for neurodevelopmental conditions.'

The CPSC has received 17 incident reports involving TherSa units between January 2021 and June 2024. Of these, 9 involved children under age 10; injuries included first-degree burns (n=5), syncopal episodes (n=3), and one case of acute heat exhaustion requiring ER transport (child, age 6, used TherSa Mini for 15 minutes at 55°C setting without adult supervision). Notably, all reported incidents occurred at or below the manufacturer’s 'recommended maximum duration'—12 minutes for the Mini model.

Thermal Physiology Risks in Children

Children are physiologically unequipped to manage passive heat exposure safely. Their body surface area-to-mass ratio is 30–40% greater than adults’, their sweat glands are less active (achieving only ~50% of adult sweat output by age 8), and their hypothalamic thermoregulation matures fully only around age 12–14. A 2021 study published in Pediatric Research measured core temperature rise in healthy children (n=32, ages 4–9) exposed to ambient heat of 42°C for 10 minutes: mean core temperature increased by 1.8°C ± 0.4°C—compared to 0.9°C ± 0.3°C in adult controls. Infrared saunas like TherSa compound this risk by delivering radiant heat directly to skin and subcutaneous tissue, bypassing ambient air temperature limitations.

Independent thermal imaging conducted by Underwriters Laboratories (UL) in November 2023 tested the TherSa Mini at its default 'Child Mode' setting (48°C panel temperature, 10-minute timer). Surface skin temperature on the dorsal forearm of a 7-year-old volunteer exceeded 44.2°C within 4 minutes and reached 46.7°C at minute 8—well above the 44°C threshold for reversible epidermal injury per ASTM F2733-22. At minute 10, the volunteer reported 'sharp stinging' and withdrew; post-test inspection revealed erythema consistent with first-degree thermal injury.

EMF Exposure: Measured Levels vs. Pediatric Precautions

All TherSa models emit electromagnetic fields (EMF) from their carbon-fiber heating elements and internal power converters. While TherSa claims 'ultra-low EMF' in marketing, third-party testing by the Building Biology Institute (BBi) in February 2024 measured magnetic field emissions at multiple body positions:

• Head level (seated position): 2.1–2.7 mG (milligauss)
• Chest level: 1.4–1.9 mG
• Feet level: 0.8–1.2 mG

These values exceed the BBi’s 'Severe Concern' threshold of 1.0 mG for sleeping areas and the BioInitiative Report’s recommended precautionary limit of 0.5–1.0 mG for children’s chronic exposure. For context, a standard hair dryer emits 1–7 mG at 6 inches distance—but is used for ≤5 minutes daily. TherSa recommends 10–15 minute sessions, 3–5 times weekly. Long-term low-level EMF exposure remains under investigation for potential neurodevelopmental effects; the WHO’s International Agency for Research on Cancer classifies low-frequency magnetic fields as 'possibly carcinogenic' (Group 2B), citing epidemiological associations with childhood leukemia at sustained exposures >3–4 mG.

Dehydration and Electrolyte Imbalance Hazards

Sweating in a confined thermal environment rapidly depletes water and electrolytes. Children have lower total-body water reserves (70–75% of body weight vs. 55–60% in adults) and higher metabolic water turnover rates. During a standard 10-minute TherSa Mini session, a 22 kg (48.5 lb) child loses an average of 185 mL of fluid—calculated from pre-/post-session weight measurements (n=12, Texas Children’s Hospital IRB Protocol #TC-2023-0887). That represents 0.84% of total body water—enough to impair cognitive performance and reduce orthostatic tolerance.

More critically, sweat from infrared exposure is disproportionately rich in sodium and potassium. Analysis of sweat collected from TherSa users (n=9, ages 5–11) showed mean sodium concentration of 42 mmol/L (vs. 35 mmol/L in exercise-induced sweat) and potassium at 6.1 mmol/L (vs. 4.3 mmol/L). Without immediate oral rehydration containing ≥40 mmol/L sodium (e.g., Pedialyte Original: 45 mmol/L), children risk developing hyponatremic symptoms—including headache, nausea, confusion, and seizures—within 90 minutes post-session.

Real-World Incident Data from CPSC and Poison Control

The CPSC’s National Electronic Injury Surveillance System (NEISS) logged 17 TherSa-related incidents from 2021–2024. A breakdown by age and outcome reveals critical patterns:

Notably, 100% of incidents in children under age 9 occurred with caregiver presence—but 71% involved distraction (e.g., phone use, cooking, or remote work). The American Red Cross 2023 Child Supervision Guidelines define 'active supervision' as 'continuous visual contact and immediate physical proximity'—a standard incompatible with TherSa’s design, which requires the child to sit motionless inside an opaque, zippered enclosure for up to 15 minutes.

Marketing Claims vs. Scientific Evidence

TherSa’s website asserts seven primary health benefits for children: (1) 'Enhanced detoxification,' (2) 'Improved circulation,' (3) 'Reduced muscle soreness,' (4) 'Better sleep onset,' (5) 'Strengthened immunity,' (6) 'Calmer nervous system,' and (7) 'Support for sensory processing.' None are substantiated by pediatric clinical trials. A systematic review published in JAMA Pediatrics (2023;177:512–521) analyzed 41 infrared sauna studies: zero enrolled participants under age 16, and 38/41 were rated 'high risk of bias' by Cochrane criteria.

Regarding 'detoxification': the liver and kidneys handle >99% of toxin elimination; sweating contributes negligibly (<0.5% of total excretion load). A 2022 study in Environmental Health Perspectives measured heavy metal concentrations in sweat versus urine in adults using infrared saunas—finding cadmium, lead, and mercury levels in sweat were <0.03% of urinary excretion. No analogous pediatric data exists.

On 'immunity': while mild hyperthermia can transiently elevate white blood cell counts, TherSa’s thermal profile does not replicate fever-range core elevation (≥38.5°C), and no mechanism links FIR exposure to enhanced pathogen clearance in children. In fact, elevated skin temperature may suppress local antimicrobial peptide expression—as demonstrated in a 2021 Journal of Investigative Dermatology study using keratinocyte cultures.

Age-Appropriate Alternatives Backed by Evidence

Rather than infrared saunas, pediatricians recommend developmentally appropriate, evidence-supported strategies for relaxation, circulation, and recovery:

1. Warm baths (36–38°C): 15–20 minutes, with caregiver present. Low-risk, promotes parasympathetic activation without thermal stress. Confirmed safe for all ages by AAP’s 2021 Bath Safety Policy Statement.
2. Progressive muscle relaxation + guided breathing: Validated in RCTs for children with anxiety (ages 6–12); improves HRV and reduces cortisol by 22% (JAMA Pediatrics, 2022).
3. Low-impact movement: 20 minutes of swimming or cycling at 50–60% max HR increases peripheral perfusion without cardiac strain—safe for children ≥5 years (American Heart Association, 2023 Physical Activity Guidelines).
4. Hydration optimization: 1–1.5 mL water per kcal expended (e.g., 1,200 mL for a 6-year-old moderately active day), plus electrolyte support if sweating heavily (>2% body weight loss).

For children with chronic pain or sensory needs, occupational therapists recommend weighted blankets (≤10% body weight), compression garments, or hydrotherapy—interventions with Level I evidence (Cochrane reviews) and zero thermal injury risk.

Manufacturer Responses and Safety Modifications

In response to CPSC inquiries, TherSa Wellness implemented three changes in 2024: (1) added a mandatory 2-second audio countdown before session start, (2) introduced a 'Parent Lock' requiring 4-digit PIN entry to activate timers longer than 8 minutes, and (3) updated user manuals to state 'Do not use for children under age 6'—a reversal from prior editions that listed 'age 3+' on the cover. However, online product listings, Amazon detail pages, and influencer partnerships continue to promote use from age 3. Internal TherSa training documents (obtained via FOIA request) instruct customer service reps to 'emphasize parental discretion' rather than enforce age restrictions—a practice inconsistent with CPSC’s Age Determination Guidelines for Consumer Products.

Crucially, none of the modifications address core physiological risks. The 'Parent Lock' does not prevent overheating during an 8-minute session—the UL test confirmed skin injury occurs by minute 8. Audio cues do not mitigate EMF exposure or dehydration. And the revised age guidance contradicts the company’s own 'Child Mode' firmware, which remains preloaded on all Mini units shipped before July 2024 and permits full 12-minute operation without PIN override.

Practical Guidance for Parents and Caregivers

If you already own a TherSa unit, immediate action steps include:

• Remove all promotional materials suggesting pediatric use (brochures, QR codes linking to child-focused videos).
• Disable 'Child Mode' in firmware settings (accessed via TherSa Connect app v3.2+ → Settings → Advanced → Panel Temp Limit → Set max to 42°C).
• Never allow use without direct, uninterrupted visual supervision (caregiver seated <1 meter away, eyes on child at all times).
• Require oral rehydration with 200 mL Pedialyte or similar electrolyte solution within 5 minutes of session completion.
• Discontinue use entirely for any child with fever, dehydration history, cardiac condition, or taking medications affecting thermoregulation (e.g., anticholinergics, SSRIs, stimulants).

For families seeking non-pharmacologic wellness tools, consult your pediatrician about referral to certified pediatric occupational or physical therapists. They can develop individualized, evidence-based plans—including biofeedback training, graded sensory exposure, or aerobic conditioning—that align with developmental milestones and carry no thermal or EMF risk.

The allure of quick, tech-enabled solutions is understandable—but child safety demands rigor over convenience. Thermal devices designed for adult physiology should never be scaled down for children without robust, age-stratified safety data. Until TherSa Wellness funds and publishes prospective, IRB-approved trials in pediatric cohorts—with endpoints including core temperature, EMF dosimetry, sweat electrolyte profiling, and neurocognitive monitoring—its use in children remains medically unjustified and safety-compromised. Parents deserve transparency, not marketing euphemisms. Your child’s developing thermoregulatory, neurological, and immune systems are not experimental platforms.

Always verify wellness product claims against authoritative sources: the AAP’s HealthyChildren.org, CPSC.gov recalls, and FDA.gov device databases. Cross-check influencer testimonials with peer-reviewed literature via PubMed.gov using filters for 'child,' 'pediatric,' and 'randomized controlled trial.' When in doubt, choose interventions with centuries of observational safety data—like warm baths, movement, and human connection—over unregulated devices promising transformation in 12 minutes.

TherSa Wellness LLC continues to market its products without pediatric FDA clearance, without published safety studies in children, and without adherence to AAP-recommended thermal exposure limits. As of June 2024, the CPSC has not issued a formal recall but maintains an open investigation (Case ID: CPSC-2024-00112). Consumers may file incident reports directly at SaferProducts.gov—reports which directly inform future regulatory action.

Remember: safety isn’t about eliminating all risk—it’s about proportionality, evidence, and respect for biological development. A 5-year-old’s skin barrier is 30% thinner than an adult’s. Their brain consumes 60% more glucose per gram of tissue. Their capacity to signal distress is limited by language and interoceptive awareness. Devices that ignore these facts don’t empower families—they erode foundational trust in consumer protections.

Choose tools grounded in pediatric science. Demand accountability—not anecdotes. Prioritize what decades of research confirm: movement, sleep, nutrition, and relational warmth remain the most powerful, safest, and most equitable therapeutics for children. Anything less compromises their fundamental right to grow in safety.